The last time the U.S. Department of Agriculture estimated the cost of raising kids in 2015, the total was $233,610 from ...

Novo Nordisk NVO announced the submission of a new drug application (NDA) to the FDA, seeking approval for its ...

Your bedroom should feel like a calm retreat, but small design choices and daily habits can quietly turn it into a chaotic ...

Ling, A. and Pandya, N. (2025) Quantum Computing and Quantum Sensing: A Pedagogical Introduction to Emerging Quantum ...

Traditional analog political systems in Nepal are increasingly incompatible with the cyber-augmented citizenry, requiring a ...

That Senior HR Exec speaks publicly about the Coldplay moment that may have made her unemployable - and the online threats ...

The filing comes as Novo fights tooth-and-nail with rival Lilly to regain its footing at the top of the weight loss market.

Novo Nordisk filed an FDA application for weekly CagriSema after trials showed up to 22.7% weight loss versus placebo.

Novo Nordisk (whose injectable weight-loss medication Wegovy is shown here) and rival Eli Lilly are both developing a new generation of obesity drugs. Eli Lilly and Novo Nordisk - the dominant players ...

Novo Nordisk's (DK:NOVO.B) next-gen medication is called CagriSema. It's a once-weekly shot that combines a long-acting amylin analogue and Wegovy. Clinical trials found that patients taking CagriSema ...

Novo Nordisk (NVO) stock gains as the company files for FDA approval of CagriSema, its next-gen obesity drug which causes up ...

The New Yorker’s editors and critics choose this year’s essential reads in fiction, poetry, and nonfiction.